• Exchange: Indonesia
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Indofarma Persero Tbk PT

+ Add to Watchlist


359 IDR 3 0.84%

As of 04:13:19 ET on 12/24/2014.

Snapshot for Indofarma Persero Tbk PT (INAF)

Open: 357 Day's Range: 355 - 374 Volume: 8,835,000
Previous Close: 356 52wk Range: 151 - 410 1-Yr Rtn: +134.64%

Stock Chart for INAF

No chart data available.
  • INAF:IJ 359
  • 1D
  • 1M
  • 1Y
Interactive INAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INAF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. JCI -
Earnings Per Share (IDR) (ttm) -9.2730
Est. EPS (IDR) (12/2014) -
Est. PEG Ratio -
Market Cap (M IDR) 1,112,637.03
Shares Outstanding (M) 3,099.27
30 Day Average Volume 15,435,360
Price/Book (mrq) 2.0043
Price/Sale (ttm) 0.7469
Dividend Indicated Gross Yield -%
Cash Dividend (IDR) 1.3700
Dividend Ex-Date 05/03/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INAF

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for INAF

PT Indofarma Tbk manufactures and trades drugs. The Company's products include generic, branded, licensed, and over the counter (OTC) drugs as well as traditional herbs, health food, cosmetics, and supplementary baby food. Through its subsidiaries, Indofarma also produces packaging materials, machinery and equipment, and infrastructure related to pharmaceutical industry.

Akmal TaherPresident CommissionerElfiano RizaldiPresident Director
John Guntar SebayangDir:Finance&Human ResourcesBambang Solihin IriantoDir:Operation&Development
More Company Profile & Key Executives for INAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil